What does APOTHEEK DASSEN do?

APOTHEEK DASSEN is a pharmacy in Scherpenheuvel-Zichem. Public Limited, started on 7 December 1984, 1 establishment.

What is the address of APOTHEEK DASSEN?

The registered office of APOTHEEK DASSEN is located at Molenstraat(S) 6, 3270 Scherpenheuvel-Zichem.

Is APOTHEEK DASSEN still active?

Yes. According to the CBE (30 October 2026) APOTHEEK DASSEN is active, legal situation “Normale toestand”, started on 7 December 1984.

Is APOTHEEK DASSEN registered on Peppol?

Yes, APOTHEEK DASSEN is registered on the Peppol network with ID 0208:0426517908.

What is the enterprise number of APOTHEEK DASSEN?

The enterprise number of APOTHEEK DASSEN is BE0426517908.

When was APOTHEEK DASSEN founded?

APOTHEEK DASSEN was founded on 7 December 1984.

Who are the directors of APOTHEEK DASSEN?

According to the 2025 annual accounts, the directors of APOTHEEK DASSEN are: DAHO BV.

Is APOTHEEK DASSEN a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 December 1984; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did APOTHEEK DASSEN make in 2025?

APOTHEEK DASSEN posted a profit after taxes of € 286,565 in financial year 2025.

What is the revenue of APOTHEEK DASSEN?

As a small company, APOTHEEK DASSEN is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 558,999.

How much does an employee at APOTHEEK DASSEN earn?

The average wage cost per full-time employee at APOTHEEK DASSEN was € 99,100 in 2025: staff costs of € 148,660 for 1.5 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does APOTHEEK DASSEN have?

According to the 2025 annual accounts, APOTHEEK DASSEN has 1.5 full-time equivalents (FTE).

APOTHEEK DASSEN (Public Limited) - Scherpenheuvel-Zichem

Dossier APOTHEEK DASSEN, printed on 30 October 2026 from databakkes.be/en/0426517908/apotheek-dassen. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

APOTHEEK DASSEN from Scherpenheuvel-Zichem, company number BE0426517908, closed financial year 2025 with a result of € 286,565 after tax. For that financial year APOTHEEK DASSEN recorded a gross margin of € 558,999 and equity of € 196,113. Compared with financial year 2024, the result moved from € 309,919 to € 286,565. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2026.

What it is worth Growing

€ 196,113

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 286,565

▼ 8% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 620,011

▼ 31% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 286,000 paid out

100 % of the profit went to the shareholders, mostly to DAHO (100 % of the shares). That is where the money ends up.

People and assets in 2025

Full-time equivalents

1.5

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 148,660

€ 99,100 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 13,318

▲ 27% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 129,821

▲ 13% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 20,724

▲ 8% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 489,257 Gross margin 2022: € 489,257 First fiscal year in the series	€ 534,423 Gross margin 2023: € 534,423 ▲ 9% vs 2022 (€ 489,257) Favourable step	€ 512,462 Gross margin 2024: € 512,462 ▼ 4% vs 2023 (€ 534,423) Unfavourable step	€ 558,999 Gross margin 2025: € 558,999 ▲ 9% vs 2024 (€ 512,462) Favourable step	▲ 9%
Profit after taxes	€ 286,662 Profit after taxes 2022: € 286,662 First fiscal year in the series	€ 338,316 Profit after taxes 2023: € 338,316 ▲ 18% vs 2022 (€ 286,662) Favourable step	€ 309,919 Profit after taxes 2024: € 309,919 ▼ 8% vs 2023 (€ 338,316) Unfavourable step	€ 286,565 Profit after taxes 2025: € 286,565 ▼ 8% vs 2024 (€ 309,919) Unfavourable step	▼ 8%
Equity	€ 195,413 Equity 2022: € 195,413 First fiscal year in the series	€ 195,478 Equity 2023: € 195,478 Unchanged (€ 195,413) Favourable step	€ 195,548 Equity 2024: € 195,548 Unchanged (€ 195,478) Favourable step	€ 196,113 Equity 2025: € 196,113 Unchanged (€ 195,548) Favourable step
Total debts	€ 1,214,775 Total debts 2022: € 1,214,775 First fiscal year in the series	€ 1,374,089 Total debts 2023: € 1,374,089 ▲ 13% vs 2022 (€ 1,214,775) Unfavourable step	€ 1,389,906 Total debts 2024: € 1,389,906 ▲ 1% vs 2023 (€ 1,374,089) Unfavourable step	€ 1,004,497 Total debts 2025: € 1,004,497 ▼ 28% vs 2024 (€ 1,389,906) Favourable step	▼ 28%
Cash	€ 760,362 Cash 2022: € 760,362 First fiscal year in the series	€ 874,843 Cash 2023: € 874,843 ▲ 15% vs 2022 (€ 760,362) Favourable step	€ 894,340 Cash 2024: € 894,340 ▲ 2% vs 2023 (€ 874,843) Favourable step	€ 620,011 Cash 2025: € 620,011 ▼ 31% vs 2024 (€ 894,340) Unfavourable step	▼ 31%
Land & buildings	€ 155,370 Land & buildings 2022: € 155,370 First fiscal year in the series	€ 145,111 Land & buildings 2023: € 145,111 ▼ 7% vs 2022 (€ 155,370) Unchanged	€ 134,852 Land & buildings 2024: € 134,852 ▼ 7% vs 2023 (€ 145,111) Unchanged	€ 124,672 Land & buildings 2025: € 124,672 ▼ 8% vs 2024 (€ 134,852) Unchanged	▼ 8%
Retained profit	€ 133,413 Retained profit 2022: € 133,413 First fiscal year in the series	€ 133,478 Retained profit 2023: € 133,478 Unchanged (€ 133,413) Favourable step	€ 133,548 Retained profit 2024: € 133,548 Unchanged (€ 133,478) Favourable step	€ 134,113 Retained profit 2025: € 134,113 Unchanged (€ 133,548) Favourable step
Dividend	€ 286,600 Dividend 2022: € 286,600 First fiscal year in the series	€ 338,250 Dividend 2023: € 338,250 ▲ 18% vs 2022 (€ 286,600) Unchanged	€ 309,850 Dividend 2024: € 309,850 ▼ 8% vs 2023 (€ 338,250) Unchanged	€ 286,000 Dividend 2025: € 286,000 ▼ 8% vs 2024 (€ 309,850) Unchanged	▼ 8%
Balance sheet total	€ 1,410,187 Balance sheet total 2022: € 1,410,187 First fiscal year in the series	€ 1,569,567 Balance sheet total 2023: € 1,569,567 ▲ 11% vs 2022 (€ 1,410,187) Unchanged	€ 1,585,454 Balance sheet total 2024: € 1,585,454 ▲ 1% vs 2023 (€ 1,569,567) Unchanged	€ 1,200,610 Balance sheet total 2025: € 1,200,610 ▼ 24% vs 2024 (€ 1,585,454) Unchanged	▼ 24%
Employees (FTE)	2 Employees (FTE) 2022: 2 First fiscal year in the series	1.5 Employees (FTE) 2023: 1.5 ▼ 0.5 vs 2022 (2) Unchanged	1.5 Employees (FTE) 2024: 1.5 Unchanged (1.5) Unchanged	1.5 Employees (FTE) 2025: 1.5 Unchanged (1.5) Unchanged

Key figures of APOTHEEK DASSEN, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to APOTHEEK DASSEN?

What happened at APOTHEEK DASSEN in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 25, 2026 New annual accounts for financial year 2025: profit of € 286,565 (▼ 8% vs 2024). filed late Source: NBB ↗
2023 DAHO BV became a director. NBB
Jan 1, 1985 New establishment in Scherpenheuvel-Zichem. KBO
Dec 7, 1984 Start of the company according to the CBE. KBO

In short

From € 286,662 profit in 2022 to € 286,565 profit in 2025.

Paid € 73,673 in corporate taxes since 2022.

Best year ever: 2023, with € 338,316 profit.

On average € 372,700 of value added per employee in 2025.

Original PDFs at the National Bank ↗

Management

DAHO 100%

The stake of DAHO comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.

APOTHEEK DASSEN

Behind APOTHEEK DASSEN is DAHO BV. The shares are held by DAHO (100%).

Directors

According to the 2025 annual accounts

DAHO BV

Director · represented by Dassen Philippe

Also active at: Apotheek Mannenberg

since 2023

Shareholders

DAHO

100%

Participations

No participations in other companies reported.

Establishments

Establishment units

Physical locations of this company

Registered office

Molenstraat(S) 6

3270 Scherpenheuvel-Zichem

2.025.902.012

Basilieklaan 22 A

3270 Scherpenheuvel-Zichem

Active since 1 January 1985

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

Dava Management

€ 56,730 gross margin · 2025

DAHO same network

€ 1.3 million gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0426.517.908

VAT number

BE 0426.517.908

Registered office

Molenstraat(S) 6, 3270 Scherpenheuvel-Zichem

Names & denominations

APOTHEEK DASSEN

Enterprise type

Rechtspersoon

Legal form

Public limited company

Legal situation

Normale toestand

Start date

7 December 1984

Peppol

Active · Active since 24 Nov 2023

Activities · NACE

Detailhandel in farmaceutische producten

Apothekers

View on CBE Public ↗ Annual accounts (NBB) ↗

APOTHEEK DASSEN

Financials

What happened to APOTHEEK DASSEN?

Management

Directors

Shareholders

Participations

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions